Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Liabilities and Shareholders Equity (2016 - 2025)

Prestige Consumer Healthcare has reported Liabilities and Shareholders Equity over the past 15 years, most recently at $3.5 billion for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $3.5 billion for Q4 2025, up 4.96% from a year ago — trailing twelve months through Dec 2025 was $13.8 billion (up 3.76% YoY), and the annual figure for FY2025 was $3.4 billion, up 2.53%.
  • Liabilities and Shareholders Equity for Q4 2025 was $3.5 billion at Prestige Consumer Healthcare, up from $3.4 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for PBH hit a ceiling of $3.7 billion in Q4 2022 and a floor of $3.3 billion in Q2 2024.
  • Median Liabilities and Shareholders Equity over the past 5 years was $3.4 billion (2021), compared with a mean of $3.5 billion.
  • Biggest five-year swings in Liabilities and Shareholders Equity: increased 7.04% in 2022 and later dropped 10.93% in 2023.
  • Prestige Consumer Healthcare's Liabilities and Shareholders Equity stood at $3.7 billion in 2021, then rose by 2.47% to $3.7 billion in 2022, then decreased by 10.93% to $3.3 billion in 2023, then fell by 0.31% to $3.3 billion in 2024, then increased by 4.96% to $3.5 billion in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $3.5 billion (Q4 2025), $3.4 billion (Q3 2025), and $3.4 billion (Q2 2025) per Business Quant data.